Status: current, Defined. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4822441000168119 | estradiol + norethisterone acetate + relugolix (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4822451000168117 | relugolix + estradiol + norethisterone acetate | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4822611000168116 | relugolix + oestradiol + norethisterone acetate | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| relugolix + estradiol + norethisterone acetate | Is a | estradiol + norethisterone acetate | true | Inferred relationship | Some | ||
| relugolix + estradiol + norethisterone acetate | has intended active ingredient | estradiol | true | Inferred relationship | Some | 247364683 | |
| relugolix + estradiol + norethisterone acetate | has intended active ingredient | relugolix | true | Inferred relationship | Some | 1610986496 | |
| relugolix + estradiol + norethisterone acetate | has intended active ingredient | norethisterone acetate | true | Inferred relationship | Some | 1406975544 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| relugolix 40 mg + estradiol 1 mg + norethisterone acetate 500 microgram tablet | Is a | True | relugolix + estradiol + norethisterone acetate | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR